Feed / SYRE

Spyre Therapeutics, Inc.

SYRE

Healthcare · 98.26 -3.1% today

Jodie read · what matters now

Spyre Therapeutics, Inc. is being tracked across filings, market groups, and disclosed business relationships.

The story is only the start. Jodie keeps watching the filing evidence, the companies connected to SYRE, and whether its market group begins moving.

Latest storyNo Struct brief yetJodie is monitoring new filings.
Disclosed connections13 verified links10 additional receipts in Pro
Organic co-movement groupClinical Biopharmaceuticals · Early FollowerDiscovered from trading behaviour, not sector labels · Open group →

Who this business touches

The relationships behind SYRE

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

MRKMerck & Company, Inc.partnerFull receipt with Pro →
TAKTakeda Pharmaceutical Company LpartnerFull receipt with Pro →

Depended on by

ABSIAbsci CorporationcompetitorFull receipt with Pro →

Filing peers

Companies whose filings use similar operating language.

You can see the shape of the network here. Pro opens 10 more links, the original filing receipts, and alerts when connected names begin moving. See Pro →

What is moving around it

Live connections

SYRE is currently a Early Follower in the organic co-movement group Clinical Biopharmaceuticals. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

Theme membership history

No durable theme membership has been observed for this name yet.